By 2034, the life science market is projected to reach a value of $269 billion globally. St. Louis is right at the center of this trend. Since its inception, BioSTL has been the convener of a coalition of partners to position St. Louis as the U.S. hub for ag tech and health innovation – two of the region’s most distinct competitive strengths. Today, \ BioSTL has created a vibrant, accessible bioscience-driven economy to improve the human condition locally and globally.
For 25 years, BioSTL has pursued its mission to ensure St. Louis is at the frontier of the world’s growing demand for bioscience innovation. The mission is rooted in St. Louis’ long established competitive strengths – human health and agricultural innovation. The region is home to both the world-changing Human Genome Project and the largest number of plant scientists in the world, to name just a couple of reasons. BioSTL was founded with the goal to grow an accessible, bioscience-driven local economy for generations to come, while establishing the region as a globally recognized hub for bioscience innovation. Today, St. Louis has become a magnet for global entrepreneurs and investors. The region is entering a new era of growth — with startups, investments, and partnerships, putting St. Louis at the center of U.S. bioscience.
H&S has collaborated with BioSTL leadership for 18 months, starting with the development of the organization’s brand strategy, design and architecture. Since then, our team has consulted with BioSTL and BioGenerator Ventures, its startup arm, on both physical and digital brand expressions, expanding the organization’s reach and community.